Macular Degeneration Association

Therapeutic Areas: Oncology | Hematology | Musculoskeletal

Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35249

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Birmingham Alabama 35249-6909

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Birmingham Alabama 35233

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Birmingham Alabama 35249

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Huntsville Alabama 35805

Patients are needed to participate in a clinical research study evaluating Obinutuzumab, Ublituximab, TGR-1202 and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Huntsville Alabama 35805

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Birmingham Alabama 35294

A clinical research study of Standard dose cytarabine for induction, SGN-CD33A, Daunorubicin and High dose cytarabine for consolidation for the treatment of Acute Myeloid Leukemia or Acute Myelogenous Leukemia (AML)

Birmingham Alabama 35294

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

A clinical trial to evaluate treatments using AMG 232 for patients with Acute Myeloid Leukemia

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Muscle Shoals Alabama 35661

A clinical research study for the treatment of Chronic Myeloid Leukemia

Muscle Shoals Alabama 35661

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Alaska

Anchorage Alaska 99503

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Arizona

UPDATED

Chandler Arizona 85224

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Oro Valley Arizona 85755

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Glendale Arizona 85308

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Phoenix Arizona 85027

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Scottsdale Arizona 85259-5499

Patients are needed to participate in a clinical research study of SGI-110 (guadecitabine) and Treatment Choice to evaluate Acute Myeloid Leukemia (AML)

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Sedona Arizona 86336

A clinical research study for the treatment of Chronic Myeloid Leukemia

Tucson Arizona 85704

A clinical research study for the treatment of Chronic Myeloid Leukemia

Tucson Arizona 85724

A Phase 3 clinical study for patients with AML

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Tucson Arizona 85710

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Arkansas

UPDATED

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study evaluating Obinutuzumab, Ublituximab, TGR-1202 and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Hot Springs Arkansas 71913

A clinical research study for the treatment of Chronic Myeloid Leukemia

Jonesboro Arkansas 72401

A clinical research study for the treatment of Chronic Myeloid Leukemia

Little Rock Arkansas 72205

A clinical research study for the treatment of Chronic Myeloid Leukemia

California

UPDATED

Anaheim California 92801

A Phase 3 clinical study for patients with Chronic Lymphocytic Leukemia, High Risk

UPDATED

Bakersfield California 93309

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Duarte California 91010

A clinical research study of Dasatinib for the treatment of Chronic Phase Chronic Myeloid Leukemia

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of KTE-C19 to evaluate Acute Lymphoblastic Leukemia (ALL)

UPDATED

Fullerton California 92835

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Irvine California 92868

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

UPDATED

La Jolla California 92037-0845

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia